World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
78
Citations
30306
World Ranking
4461
National Ranking
2167

Medicine

D-Index
79
Citations
30469
World Ranking
17391
National Ranking
8710

Overview

Katayoun Rezvani is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily spans the fields of medicine and immunology and microbiology, with a particular focus on immunology, hematology, oncology, molecular biology, and genetics.

Their scholarly output includes work on various topics such as CAR-T cell therapy research, immune cell function and interaction, hematopoietic stem cell transplantation, T-cell and B-cell immunology, acute myeloid leukemia research, acute lymphoblastic leukemia research, and cytomegalovirus and herpesvirus research.

Rezvani's recent publications include:

  • Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors, 2020, New England Journal of Medicine
  • Natural killer cells in antitumour adoptive cell immunotherapy, 2022, Nature Reviews. Cancer
  • Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial, 2024, Nature Medicine
  • Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells, 2020, Blood
  • Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells, 2021, Journal of Clinical Investigation

Frequent coauthors collaborating with Rezvani include Elizabeth J. Shpall, Richard E. Champlin, Partow Kebriaei, May Daher, and David Marín.

The scientist regularly publishes in journals such as Blood, Transplantation and Cellular Therapy, bioRxiv (Cold Spring Harbor Laboratory), Blood Advances, and British Journal of Haematology.

Best Publications

  • Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

    V. Gopalakrishnan;V. Gopalakrishnan;C. N. Spencer;C. N. Spencer;L. Nezi;A. Reuben

  • B cells and tertiary lymphoid structures promote immunotherapy response

    Beth A. Helmink;Sangeetha M. Reddy;Jianjun Gao;Shaojun Zhang

  • Chimeric antigen receptor T-cell therapy — assessment and management of toxicities

    Sattva S. Neelapu;Sudhakar Tummala;Partow Kebriaei;William Wierda

  • Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

    Enli Liu;David Marin;Pinaki Banerjee;Homer A. Macapinlac

  • Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity

    Enli Liu;Yijiu Tong;Gianpietro Dotti;Hila Shaim

  • Generation and testing of clinical-grade exosomes for pancreatic cancer

    Mayela Mendt;Sushrut Kamerkar;Hikaru Sugimoto;Kathleen M. McAndrews

  • Mesenchymal stem cell-derived exosomes for clinical use.

    Mayela Mendt;Katayoun Rezvani;Elizabeth Shpall

  • Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy.

    Amr R Ibrahim;Lina Eliasson;Jane F Apperley;Dragana Milojkovic

  • Engineering Natural Killer Cells for Cancer Immunotherapy

    Katayoun Rezvani;Rayne Rouce;Enli Liu;Elizabeth Shpall

  • Deficient CD4 + CD25 + FOXP3 + T regulatory cells in acquired aplastic anemia

    Elena E. Solomou;Katayoun Rezvani;Stephan Mielke;Daniela Malide

  • The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer

    Katayoun Rezvani;Rayne H. Rouce

  • Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

    Nimitha R Mathew;Nimitha R Mathew;Francis Baumgartner;Lukas Braun;David O'Sullivan

  • Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer.

    Rohtesh S. Mehta;Katayoun Rezvani

  • The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden.

    Bianca Santomasso;Carlos Bachier;Jason Westin;Katayoun Rezvani

  • Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.

    Antonio Di Stasi;Denái R. Milton;L.M. Poon;Amir Hamdi

  • Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD

    Ahmad Khoder;Anushruti Sarvaria;Abdullah Alsuliman;Claude Chew

  • Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering.

    May Daher;Katayoun Rezvani

  • Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells

    May Daher;Rafet Basar;Elif Gokdemir;Natalia Baran

  • Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy

    Kris M. Mahadeo;Sajad J. Khazal;Hisham Abdel-Azim;Julie C. Fitzgerald

  • Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'

    Sattva S. Neelapu;Sudhakar Tummala;Partow Kebriaei;William Wierda

Frequent Co-Authors

Elizabeth J. Shpall
Elizabeth J. Shpall The University of Texas MD Anderson Cancer Center
Richard E. Champlin
Richard E. Champlin The University of Texas MD Anderson Cancer Center
Partow Kebriaei
Partow Kebriaei The University of Texas MD Anderson Cancer Center
Issa F. Khouri
Issa F. Khouri The University of Texas MD Anderson Cancer Center
Borje S. Andersson
Borje S. Andersson The University of Texas MD Anderson Cancer Center
Jane F. Apperley
Jane F. Apperley Imperial College London
William G. Wierda
William G. Wierda The University of Texas MD Anderson Cancer Center
Catherine M. Bollard
Catherine M. Bollard George Washington University
Dean A. Lee
Dean A. Lee Nationwide Children's Hospital
John M. Goldman
John M. Goldman Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Katayoun Rezvani

Trending Scientists

Recently Published Articles